BCRX into Earnings: Shorts Retreat as Momentum Builds
BioCryst Pharmaceuticals heads into its Q3 earnings release, due after the close tomorrow, with short sellers markedly less aggressive than six weeks ago and options traders showing little defensiveness despite the…